KRAS and colonic neoplasm: Based on these results we have selected the three more effective and selective IQc compounds and studied their anti-proliferative activities in a panel of KRAS-dependent and independent cancer cells, their effects on the down-regulation of KRAS expression and their ability to induce apoptosis in colon cancer cell lines with different phenotypes (HCT116 and SW620).